GeneChem Inc., a subsidiary of Soulbrain Holdings Co., Ltd., is a leading player in the glycosylation industry, particularly specializing in sialylation through its unique and efficient enzyme-based One-Pot Reaction system.
With patents for the technology registered in the US, the EU, Japan, China, and Korea, GeneChem has been providing sialyllactose for research purposes to top infant formula manufacturers and scientists around the world since 2011. The company plans to introduce additional applications of sialyllactose to the market after completion of new factory which is designed to produce 3’-sialyllactose and 6’-sialyllactose with state-of-the-art technology.
GeneChem achieved US FDA GRAS (generally recognized as safe) for 3’-sialyllactose in Sep. 2018. In addition to sialyllactose, company also produces AquaGG® (glyceryl glucoside), reagents for carbohydrate research, and other sialylated and fucosylated oligosaccharides. The company also offers customized services for sialylation and glycosylation of bioactive molecules.